MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
2025: Top 10 U.S. Biopharma Clusters 2025
North Carolina
*Industry: Research Triangle, North Carolina
*Bioscience Regional Clusters & HotSpots
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
Paragon Bioservices
Attachments
Home - Paragon Bioservices, Inc.
Parents
*Industry: Baltimore, Maryland
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
2011: Maryland Biotech Center awards $1.8M in grants (2011)
Architects: Biotechnology_Stem Cell Therapeutics
Companies: Acquired_(M&A)
Finance & Acquisitions: Catalent
University of Maryland Baltimore Biopark
Children
2019: Ahead of US gene therapy explosion, big contract drug manufacturer Catalent makes $1.2 billion bet on Paragon Bioservices – Endpoints News
Baltimore, Maryland
In 2009, Chacon signed a deal to assist the U.S. Army Medical Research Institute for Infectious Diseases (USAMRIID), in Frederick, Maryland with the development and manufacture of vaccines against the deadly Ebola and Marburg viruses.
Marco Chacon, CEO at Paragon Bioservices
Paragon contract lab continues to expand and land new work.
Paragon, which is backed by NewSpring Capital and Camden Partners and based in the University of Maryland BioPark in Baltimore, manufacturers viral vectors which are used by drug companies to deliver genetic material to cells to fix faulty genes.
stem cell consortium established with University of Maryland, Baltimore
Jumps
USAMRIID-U.S. Army Medical Research Institute of Infectious Disease